Live
FierceBiotechHow WuXi AppTec’s Integrated Platform Is Helping Therapies Move Faster from Discovery to PatientsFierceBiotechBiomarkers are reshaping oncology trial designLonza NewsLonza Group AG stock (CH0013841017): Is biopharma contract manufacturing strong enough to unlock new - AD HOC NEWSFierceBiotechFDA celebrates progress to end animal testing but experts warn there’s still a long way to goFierceBiotechAACR: Former Genentech leader engineers startup with vision for ‘smart’ cancer drugsAgilentAgilent Cancer Research Push Spurs Collaboration Focus And Investor Reassessment - Yahoo Finance10x Genomics Blog10x Genomics (TXG) Launches Atera: A Breakthrough in Spatial Bio - GuruFocusCytiva (Google News)50mm Diameter Filters Cytiva Whatman Cellulose Acetate Membranes:Filters And Filtration Sterile Filtration Membrane - primetimes.id10x Genomics Blog10x Genomics (TXG) Launches Atera: A Breakthrough in Spatial Bio - GuruFocus10x Genomics Blog10x Genomics announces Atera, a new in situ spatial biology platform - TipRanksAgilent11,390 Shares in Agilent Technologies, Inc. $A Acquired by Lecap Asset Management Ltd. - MarketBeatThermo FisherIs Thermo Fisher Scientific (TMO) Fairly Priced After Recent Share Price Rebound? - simplywall.st
Endpoints News Feb 27, 2026

Novartis closes Avidity deal as rare heart disease spinout launches

Novartis closes Avidity deal as rare heart disease spinout launches

Original
Body unavailable. Use the original source.